Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Communications|March 24, 2026
RFC4 drives temozolomide resistance in glioblastoma by activating STK38-BECN1-dependent autophagyMin Mao, Hang Ji, Wen-Qian Yu, et al.
American Journal of Cancer Research|June 12, 2018
ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cellsKang Song, Ye Yuan, Yong Lin, et al.
Plos One|June 30, 2015
HIV-1 Genetic Diversity and Its Impact on Baseline CD4+T Cells and Viral Loads among Recently Infected Men Who Have Sex with Men in Shanghai, ChinaXiaoyan Li, Yile Xue, Hua Cheng, et al.
CNS Neuroscience & Therapeutics|April 14, 2022
Targeting AKT and CK2 represents a novel therapeutic strategy for SMO constitutive activation-driven medulloblastomaYue-Liang Yao, Yan-Xia Wang, Fei-Cheng Yang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 30, 2022
Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chainFei-Cheng Yang, Chuan Wang, Jiang Zhu, et al.
Cancer Letters|November 10, 2025
Single-cell deconstruction of medulloblastoma microenvironment elucidates subtype-specific immune architectures and prognostic molecular signaturesHong Zhou, Qu-Jing Gai, Qian Yan, et al.
Plos One|March 4, 2014
Evidence that HIV-1 CRF01_AE is associated with low CD4+T cell count and CXCR4 co-receptor usage in recently infected young men who have sex with men (MSM) in Shanghai, ChinaXiaoshan Li, Yile Xue, Leiming Zhou, et al.
Cancer Letters|May 1, 2026
TRIM21 drives glioblastoma malignancy via ubiquitination-mediated PDGFRA degradationQu-Jing Gai, Chuan Wang, Si-Di Li, et al.
Theranostics|January 6, 2022
Comprehensive omics analyses profile genesets related with tumor heterogeneity of multifocal glioblastomas and reveal LIF/CCL2 as biomarkers for mesenchymal subtypeSheng-Qing Lv, Zhen Fu, Lin Yang, et al.
Signal Transduction and Targeted Therapy|February 2, 2022
EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastomaQu-Jing Gai, Zhen Fu, Jiang He, et al.
Pageof 2